Press Releases
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO) released the following statement on the release of Special Counsel Robert Mueller's report:
WASHINGTON, D.C. – Reps. Diana DeGette (D-CO) and Bill Johnson (R-OH) introduced the Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act, yesterday. The bipartisan legislation will improve patient access to podiatrists in Medicaid and improve care for patients with diabetes who need therapeutic shoes via Medicare.
WASHINGTON, D.C. – "The system is broken," U.S. Rep. Diana DeGette (D-CO), chair of the House oversight panel that's currently investigating the rising cost of insulin, told a panel of drug makers and pharmacy executives who were summoned to appear before Congress today to explain why the cost of the life-saving drug has continued to rise in recent years.
WASHINGTON, D.C. – U.S. Reps. Diana DeGette (D-CO) and Jackie Speier (D-CA) introduced legislation today to overhaul the U.S. military's policy on providing servicemembers and their families with family-planning counseling services and coverage for contraceptives.
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO), chair of the House oversight panel that's investigating the skyrocketing cost of insulin, announced today that all three U.S. manufacturers of insulin will be appearing before Congress next week.
WASHINGTON, D.C. – U.S. Reps. Diana DeGette (D-CO), Mark DeSaulnier (D-CA), Zoe Lofgren (D-CA) and Jamie Raskin (D-MD) introduced a resolution today to recognize the vital role that local journalists play in promoting good governance and accountability.
WASHINGTON, D.C. – A bipartisan group of lawmakers introduced legislation today seeking to bring down the cost of certain biologic drugs, such as insulin, by making it easier for drug makers to get generic versions of those drugs approved by the Food and Drug Administration.
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO) introduced legislation today that would prevent the federal government from enforcing its prohibition on marijuana in states, such as Colorado, where it is legal for residents to possess and use the drug.
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO), chair of the House oversight panel that's currently investigating the rising cost of insulin, announced today that her committee will hold its first of two hearings on the skyrocketing cost of the drug next Tuesday, April 2, at 10:30 a.m. ET.
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO) today urged state leaders to investigate reports that more than a half-dozen Colorado oil and gas companies are allegedly fracking along the Front Range without the necessary permits and in violation of federal law.